Vonoprazan Use During Pregnancy Study
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
- Age
- 15 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 728 (estimated)
- Sponsor
- Phathom Pharmaceuticals, Inc. · Industry
This trial is looking for pregnant women aged 15 to 50 to compare the health outcomes of those who have taken vonoprazan with those who have not. Participants will need to share information about their health and pregnancy.
You may be able to join if
- I am between 15 and 50 years old.
- I am currently or have recently been pregnant.
- I agree to participate in the trial.
- I allow my healthcare provider to share my health data.
- I have taken at least one dose of vonoprazan during my pregnancy.
- I have not taken vonoprazan but have a condition that could require it.
You may not be able to join if
- I had a pregnancy outcome before my first contact with the study.
- I have taken known harmful medications during my pregnancy.
- I have been lost to follow-up.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe main objective of the study is to compare the maternal, fetal, and infant outcomes of pregnant women who are exposed to vonoprazan during pregnancy with outcomes of an internal comparison cohort of pregnant women who are unexposed to vonoprazan during pregnancy but who may be exposed to other products for the treatment of conditions for which vonoprazan may be prescribed.
Loading trial locations…